Esorubicin
- Level
- Commodity
- Parent
- 51281800
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51281808This classification denotes an anthracycline antibiotic with the molecular formula C27H29NO10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, RMC41L2WQ3 chemically known as 5,12-naphthacenedione, 10-((4-aminotetrahydro-6-methyl-2h-pyran-2-yl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (2s-(2.alpha,(8r*,10r*),4.beta.,6.beta))- but generally known as esorubicin, which bears US NIH Compound Identifier 44554. European Medicines Agency schedules Esorubicin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12442MIG. The term ESORUBICIN is an International Non-Proprietary Name or INN. Most nations schedule esorubicin under HS 29419000 and SITC 54139. As of Q4 2014, ESORUBICIN remains the US FDA Preferred Term for this commodity. Esorubicin bears US NLM identifiers UMLS ID C0047760 and NCI Concept Code C972. SMILES: O(C1CC(O)(CC2C1C(O)C1C(C2O)C(=O)C2C(C1=O)C(OC)CCC2)C(=O)CO)C1OC(CC(N)C1)C.
Same parent
Under 51281800 · 24Activities that produce or sell this
KBLI · 9Inherited from family 51280000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.